The Latest Headlines at American Banking and Market News
New York Life Investment Management LLC Sells 811 Shares of N-able, Inc. (NYSE:NABL)
New York Life Investment Management LLC reduced its position in N-able, Inc. (NYSE:NABL – Free Report) by 3.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission... More of this article »
New York Life Investment Management LLC Cuts Stock Holdings in Cullinan Oncology, Inc. (NASDAQ:CGEM)
New York Life Investment Management LLC cut its position in shares of Cullinan Oncology, Inc. (NASDAQ:CGEM – Free Report) by 3.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional... More of this article »
New York Life Investment Management LLC Has $344,000 Position in HealthStream, Inc. (NASDAQ:HSTM)
New York Life Investment Management LLC lessened its stake in HealthStream, Inc. (NASDAQ:HSTM – Free Report) by 3.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned... More of this article »
New York Life Investment Management LLC Sells 399 Shares of Box, Inc. (NYSE:BOX)
New York Life Investment Management LLC reduced its stake in Box, Inc. (NYSE:BOX – Free Report) by 3.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional... More of this article »
New York Life Investment Management LLC Has $337,000 Stock Position in Horace Mann Educators Co. (NYSE:HMN)
New York Life Investment Management LLC cut its holdings in shares of Horace Mann Educators Co. (NYSE:HMN – Free Report) by 3.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission.... More of this article »
New York Life Investment Management LLC Sells 170 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)
New York Life Investment Management LLC cut its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report) by 3.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the... More of this article »
New York Life Investment Management LLC Trims Position in Travel + Leisure Co. (NYSE:TNL)
New York Life Investment Management LLC cut its stake in shares of Travel + Leisure Co. (NYSE:TNL – Free Report) by 3.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange... More of this article »
NiSource (NYSE:NI) Given “Outperform” Rating at BMO Capital Markets
BMO Capital Markets reissued their outperform rating on shares of NiSource (NYSE:NI – Free Report) in a report published on Thursday, Benzinga reports. The firm currently has a $31.00 price target on the utilities provider’s... More of this article »
BMO Capital Markets Boosts Ingredion (NYSE:INGR) Price Target to $120.00
Ingredion (NYSE:INGR – Free Report) had its price objective increased by BMO Capital Markets from $117.00 to $120.00 in a research report report published on Thursday, Benzinga reports. BMO Capital Markets currently has a market... More of this article »
Barclays Cuts Duolingo (NASDAQ:DUOL) Price Target to $230.00
Duolingo (NASDAQ:DUOL – Free Report) had its price objective lowered by Barclays from $243.00 to $230.00 in a research report released on Thursday morning, Benzinga reports. Barclays currently has an equal weight rating on the... More of this article »
International Money Express (NASDAQ:IMXI) PT Raised to $30.00 at BMO Capital Markets
International Money Express (NASDAQ:IMXI – Free Report) had its target price increased by BMO Capital Markets from $29.00 to $30.00 in a report issued on Thursday, Benzinga reports. BMO Capital Markets currently has an outperform... More of this article »
Virgin Galactic (NYSE:SPCE) PT Lowered to $0.75
Virgin Galactic (NYSE:SPCE – Free Report) had its price target lowered by Wells Fargo & Company from $1.00 to $0.75 in a research note issued to investors on Thursday morning, Benzinga reports. Wells Fargo & Company... More of this article »
Definitive Healthcare (NASDAQ:DH) Price Target Lowered to $7.00 at Barclays
Definitive Healthcare (NASDAQ:DH – Free Report) had its price target lowered by Barclays from $11.00 to $7.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has an equal weight rating... More of this article »